These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 11521229

  • 1. Mast cell involvement in fibrodysplasia ossificans progressiva.
    Gannon FH, Glaser D, Caron R, Thompson LD, Shore EM, Kaplan FS.
    Hum Pathol; 2001 Aug; 32(8):842-8. PubMed ID: 11521229
    [Abstract] [Full Text] [Related]

  • 2. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1R206H Mouse Model of Fibrodysplasia Ossificans Progressiva.
    Convente MR, Chakkalakal SA, Yang E, Caron RJ, Zhang D, Kambayashi T, Kaplan FS, Shore EM.
    J Bone Miner Res; 2018 Feb; 33(2):269-282. PubMed ID: 28986986
    [Abstract] [Full Text] [Related]

  • 3. Exoneration of NF-kappaB dysregulation in fibrodysplasia ossificans progressiva.
    Ahn J, Feldman G, Terry L, Shore EM, Kaplan FS.
    Clin Orthop Relat Res; 2003 Jan; (406):205-13. PubMed ID: 12579020
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva.
    Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS.
    N Engl J Med; 1996 Aug 22; 335(8):555-61. PubMed ID: 8678932
    [Abstract] [Full Text] [Related]

  • 5. Lumbar puncture and surgical intervention in a child with undiagnosed fibrodysplasia ossificans progressiva.
    Zaghloul KA, Heuer GG, Guttenberg MD, Shore EM, Kaplan FS, Storm PB.
    J Neurosurg Pediatr; 2008 Jan 22; 1(1):91-4. PubMed ID: 18352811
    [Abstract] [Full Text] [Related]

  • 6. Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA.
    de la Peña LS, Billings PC, Fiori JL, Ahn J, Kaplan FS, Shore EM.
    J Bone Miner Res; 2005 Jul 22; 20(7):1168-76. PubMed ID: 15940369
    [Abstract] [Full Text] [Related]

  • 7. Stromal cells of fibrodysplasia ossificans progressiva lesions express smooth muscle lineage markers and the osteogenic transcription factor Runx2/Cbfa-1: clues to a vascular origin of heterotopic ossification?
    Hegyi L, Gannon FH, Glaser DL, Shore EM, Kaplan FS, Shanahan CM.
    J Pathol; 2003 Sep 22; 201(1):141-8. PubMed ID: 12950027
    [Abstract] [Full Text] [Related]

  • 8. Mast cell inhibition as a therapeutic approach in fibrodysplasia ossificans progressiva (FOP).
    Brennan TA, Lindborg CM, Bergbauer CR, Wang H, Kaplan FS, Pignolo RJ.
    Bone; 2018 Apr 22; 109():259-266. PubMed ID: 28851540
    [Abstract] [Full Text] [Related]

  • 9. Characterization of bone morphogenetic protein 4 receptor in fibrodysplasia ossificans progressiva.
    Lanchoney TF, Olmsted EA, Shore EM, Gannon FA, Rosen V, Zasloff MA, Kaplan FS.
    Clin Orthop Relat Res; 1998 Jan 22; (346):38-45. PubMed ID: 9577408
    [Abstract] [Full Text] [Related]

  • 10. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva.
    Kitterman JA, Kantanie S, Rocke DM, Kaplan FS.
    Pediatrics; 2005 Nov 22; 116(5):e654-61. PubMed ID: 16230464
    [Abstract] [Full Text] [Related]

  • 11. Urinary basic fibroblast growth factor. A biochemical marker for preosseous fibroproliferative lesions in patients with fibrodysplasia ossificans progressiva.
    Kaplan F, Sawyer J, Connors S, Keough K, Shore E, Gannon F, Glaser D, Rocke D, Zasloff M, Folkman J.
    Clin Orthop Relat Res; 1998 Jan 22; (346):59-65. PubMed ID: 9577411
    [Abstract] [Full Text] [Related]

  • 12. Fibrodysplasia ossificans progressiva (FOP).
    Paim LB, Liphaus Bde L, Almeida da Silva CA.
    Indian Pediatr; 2003 Aug 22; 40(8):786-8. PubMed ID: 12951384
    [Abstract] [Full Text] [Related]

  • 13. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
    Kaplan FS, Glaser DL, Shore EM, Pignolo RJ, Xu M, Zhang Y, Senitzer D, Forman SJ, Emerson SG.
    J Bone Joint Surg Am; 2007 Feb 22; 89(2):347-57. PubMed ID: 17272450
    [Abstract] [Full Text] [Related]

  • 14. Radiation therapy in treatment of fibrodysplasia ossificans progressiva: a case report and review of the literature.
    Soldić Z, Murgić J, Radić J, Dabelić N, Jazvić M, Brozić JM, Kusić Z.
    Coll Antropol; 2011 Jun 22; 35(2):611-4. PubMed ID: 21755739
    [Abstract] [Full Text] [Related]

  • 15. Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva.
    Gannon FH, Valentine BA, Shore EM, Zasloff MA, Kaplan FS.
    Clin Orthop Relat Res; 1998 Jan 22; (346):19-25. PubMed ID: 9577406
    [Abstract] [Full Text] [Related]

  • 16. Fibrodysplasia ossificans progressiva.
    Blaszczyk M, Majewski S, Brzezinska-Wcislo L, Jablonska S.
    Eur J Dermatol; 2003 Jan 22; 13(3):234-7. PubMed ID: 12804980
    [Abstract] [Full Text] [Related]

  • 17. A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP).
    Kaplan FS, Al Mukaddam M, Pignolo RJ.
    Bone; 2017 Aug 22; 101():123-128. PubMed ID: 28465250
    [Abstract] [Full Text] [Related]

  • 18. Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype.
    Kan L, Hu M, Gomes WA, Kessler JA.
    Am J Pathol; 2004 Oct 22; 165(4):1107-15. PubMed ID: 15466378
    [Abstract] [Full Text] [Related]

  • 19. Consideration of Rituximab for fibrodysplasia ossificans progressiva.
    Altschuler EL.
    Med Hypotheses; 2004 Oct 22; 63(3):407-8. PubMed ID: 15288357
    [Abstract] [Full Text] [Related]

  • 20. Human leukocyte antigen B27 allele is not correlated with fibrodysplasia ossificans progressiva.
    Calvert GT, Shore EM.
    Clin Orthop Relat Res; 1998 Jan 22; (346):66-70. PubMed ID: 9577412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.